£30 · 99% Retatrutide Fat Burning Peptide CAS 2381089-83-2 No Customs Issues
Retatrutide CAS 2381089-83-2
5/10/15mg
Retatrutide (LY-3437943) is under development for the treatment of type 2 diabetes mellitus, obstructive sleep apnea, osteoarthritis, obesity and non-alcoholic fatty liver disease. The drug candidate is administered through subcutaneous and intravenous route. The drug candidate acts by targeting glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. It is a new molecular entity.
Details | Today: | Yesterday: | To Date: |
---|---|---|---|
Viewed: | |||
Browsed: | |||
Other Information | |||
Ad Id | 29591207 | ||
Category | Health | ||
Posted | May 29, 2024 | ||
Expiry | June 28, 2024 | ||
Status | EXPIRED | ||
Details | New, Commercial Seller |